NDatalyze (NDatalyze) FCF Margin % : 82.14% (As of Nov. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NDatalyze FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. NDatalyze's Free Cash Flow for the three months ended in Nov. 2023 was $0.02 Mil. NDatalyze's Revenue for the three months ended in Nov. 2023 was $0.03 Mil. Therefore, NDatalyze's FCF Margin % for the quarter that ended in Nov. 2023 was 82.14%.

As of today, NDatalyze's current FCF Yield % is -6.09%.

The historical rank and industry rank for NDatalyze's FCF Margin % or its related term are showing as below:

NDATF' s FCF Margin % Range Over the Past 10 Years
Min: -601.17 Med: -137.04 Max: 16.95
Current: -266.67

During the past 5 years, the highest FCF Margin % of NDatalyze was 16.95%. The lowest was -601.17%. And the median was -137.04%.

NDATF's FCF Margin % is ranked worse than
95.04% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 1.46 vs NDATF: -266.67

NDatalyze FCF Margin % Historical Data

The historical data trend for NDatalyze's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDatalyze FCF Margin % Chart

NDatalyze Annual Data

Trend

Feb19

Feb20

Feb21

Feb22

Feb23

FCF Margin %

-137.40

16.75

2.87

-268.26

-601.57

NDatalyze Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
FCF Margin %	Get a 7-Day Free Trial															-500.00	-635.71	-510.00	-155.56	82.14

Competitive Comparison of NDatalyze's FCF Margin %

For the Health Information Services subindustry, NDatalyze's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NDatalyze's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's FCF Margin % distribution charts can be found below:

* The bar in red indicates where NDatalyze's FCF Margin % falls into.

NDatalyze FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

NDatalyze's FCF Margin for the fiscal year that ended in Feb. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Feb. 2023 )	/	Revenue (A: Feb. 2023 )
	=	-0.764	/	0.127
	=	-601.57 %

NDatalyze's FCF Margin for the quarter that ended in Nov. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Nov. 2023 )	/	Revenue (Q: Nov. 2023 )
	=	0.023	/	0.028
	=	82.14 %

NDatalyze FCF Margin % Related Terms

Thank you for viewing the detailed overview of NDatalyze's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

NDatalyze (NDatalyze) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NDatalyze Corp (OTCPK:NDATF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

NDAT:Canada

Address

707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6

Website

https://www.ndatalyze.com

NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.

NDatalyze (NDatalyze) Headlines

From GuruFocus

nDatalyze Corp. to Webcast Live at VirtualInvestorConferences.com December 15th

By Value_Insider Value_Insider • 12-13-2022

UPDATE � Life Sciences Investor Forum: Company Executives Present Live March 10th

By GuruFocusNews GuruFocusNews • 03-08-2022